Clinical Trial

Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome

Name: Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome — clinical trial record (NCT07421427)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the additive effect of Amantadine or Duloxetine to Pregabalin on development of post mastectomy pain syndrome

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-12.

Status change: Not Yet Recruiting → Recruiting 2026-02-21

Trial Details

NCT Number	NCT07421427
Lead Sponsor	Cairo University
Conditions	Amantadine, Duloxetine, Pregabalin, Mastectomy, Pain Syndrome
Enrollment	150 participants
Start Date	2026-02-21
Primary Completion	2027-01-01 (estimated)
Study Completion	2027-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-24